SYNACT PHARMA ApS
34459975ActiveClinical-stage biotech company developing innovative therapies to resolve inflammation.
Yleiskatsaus
- 6
- Työntekijät
- Tuntematon
- Liikevaihto
- 2012
- Perustettu
Avainpäättäjät
Ann Kristin Led
Chief Financial Officer
Jeppe Øvlesen
Chief Executive Officer
Roy Fleischmann
Advisory Board Member
Ravi Rao
Advisory Board Member
+14 lisää yhteystietoja Funnelfeedrissä
Kuvaus
SynAct Pharma is a clinical-stage biotechnology company based in Sweden and Denmark that focuses on developing innovative therapies to resolve inflammation rather than simply inhibiting it. Their lead drug candidate, Resomelagon (AP1189), is a once-daily oral therapy designed to selectively activate...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tuntematon
- Oikeudellinen muoto
- APS
- ALV-numero
- DK34459975
Päättäjät
18 yhteystietoa FunnelfeedrissäAnn Kristin Led
Chief Financial Officer
Jeppe Øvlesen
Chief Executive Officer
Roy Fleischmann
Advisory Board Member
Ravi Rao
Advisory Board Member
Mauro Perretti
Advisory Board Member
Malin Wikstrand
Interim Chief Financial Officer
Jeppe Ragnar Andersen
Board Member
Thomas Boesen
Chief Operating Officer
James Knight
Advisory Board Member
Vibeke Strand
Advisory Board Member
Thomas Jonassen
Chief Scientific Officer
Sten Scheibye
Board Member
Mads Bjerregaard
Chief Business Officer
Kirsten Harting
Chief Medical Officer
Sten Sörensen
Board Member
Anders Kronborg
Chairman of the Board
Torbjørn Bjerke
Chief Executive Officer
Mauro Teixeira
Advisory Board Member
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäEvaxion A/S
44 työntekijätAI-driven TechBio company developing personalized vaccines for cancer and infections.
Novakand Pharma AB
5–9 työntekijätDeveloping novel small-molecule drugs for inflammation and cancer.
VIROGATES A/S
8 työntekijätViroGates provides innovative suPAR-based diagnostic solutions for clinical risk stratification.
BIOTAGE SWEDEN AB
Global partner providing separation and purification workflow solutions for life sciences.
Inicure AB
0 työntekijätDeveloping novel small molecules to combat resistant bacterial infections effectively.
Selaa lisää
Kysymyksiä yrityksestä SYNACT PHARMA ApS
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo